EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSMLUG00000001113
Gene Symbol: KIF5B
2 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSMLUG00000013624
Gene Symbol: LTA4H
2 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSMLUG00000029113
Gene Symbol: LTB4R2
2 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSMLUG00000010587
Gene Symbol: KDM1A
2 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSMLUG00000000270
Gene Symbol: LOXL2
2 Cross references
287 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSMLUG00000016790
Gene Symbol: MST1R
2 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSMLUG00000017263
Gene Symbol: MGAM
2 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSMLUG00000000992
Gene Symbol: MMP12
4 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSMLUG00000012908
Gene Symbol: MMP14
2 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMLUG00000004000
Gene Symbol: MMP2
2 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSMLUG00000000984
Gene Symbol: MMP3
2 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSMLUG00000008134
Gene Symbol: MMP7
2 Cross references
163 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).